Lista de obras -

A Neurologist's Perspective on Thymectomy for Myasthenia Gravis: Current Perspective and Future Trials

artículo científico publicado en 2019

A genome-wide association study of myasthenia gravis

artículo científico publicado en 2015

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

artículo científico publicado en 2008

Adult polyglucosan body disease associated with lewy bodies and tremor

artículo científico publicado en 2003

Alfred Jaretzki III, MD.

artículo científico publicado en 2014

Antibody testing in peripheral neuropathies

artículo científico publicado en 2007

Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia).

artículo científico

Author response: International consensus guidance for management of myasthenia gravis: Executive summary

artículo científico publicado en 2017

Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome

artículo científico publicado en 2003

Biomarker development for myasthenia gravis

artículo científico publicado en 2012

Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome

artículo científico publicado en 2004

CMT with vocal cord paralysis, type 2C

scholarly article

Cerebral paragonimiasis: an unusual manifestation of a rare parasitic infection

artículo científico publicado en 2014

Challenges in the identification of cobalamin-deficiency polyneuropathy

artículo científico publicado en 2003

Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sample

artículo científico publicado en 2013

Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system

artículo científico publicado en 2002

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

artículo científico publicado en 2020

Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience

scientific article published on March 2010

Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis

artículo científico publicado en 2008

Comment: Salbutamol--A means to an endplate

scientific article published on 20 January 2016

Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches

artículo científico publicado en 2009

Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis

artículo científico publicado en 2008

Consensus treatment recommendations for late-onset Pompe disease

artículo científico publicado en 2011

Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study

scientific article published on 05 May 2020

Cytokines in Guillain-Barré Syndrome

artículo científico publicado en 2011

Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial

scientific article published on 01 December 2012

Developing treatment guidelines for myasthenia gravis

artículo científico publicado en 2018

Development of a Thymectomy Trial in Nonthymomatous Myasthenia Gravis Patients Receiving Immunosuppressive Therapy ⬇️

artículo científico publicado el 1 de septiembre de 2003

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

artículo científico publicado en 2015

Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial

artículo científico publicado en 2015

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

scientific article published on 18 September 2020

Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria

artículo científico publicado en 2016

Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy

artículo científico publicado en 2003

Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.

artículo científico publicado en 2018

Idiopathic neuropathy: new paradigms, new promise.

artículo científico

Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?

scientific article published on 09 November 2019

Implementing clinical trials on an international platform: challenges and perspectives

artículo científico publicado en 2011

International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r

artículo científico publicado en 2016

International consensus guidance for management of myasthenia gravis: 2020 update

artículo científico publicado en 2020

International consensus guidance for management of myasthenia gravis: Executive summary

artículo científico publicado en 2016

Introduction for Myasthenia Gravis and Related Disorders

scientific article published on 01 December 2012

Introduction for myasthenia gravis and related disorders

scientific article published on 01 December 2012

Is the treatment of myasthenia gravis improving? Why not ask our patients?

artículo científico publicado en 2020

Isolated Neck Extensor Myopathy: Is it Responsive to Immunotherapy? ⬇️

artículo científico publicado el 1 de septiembre de 2010

Learning from the past: reflections on recently completed myasthenia gravis trials

artículo científico publicado en 2017

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

artículo científico publicado en 2019

Low-Dose Medication and Long-Term Outcome in Myasthenia Gravis

artículo científico publicado en 2016

MG‐ADL: Still a relevant outcome measure ⬇️

artículo científico publicado el 1 de noviembre de 2011

MRI vs EMG: which has the upper hand in carpal tunnel syndrome?

scientific article published on 01 June 2002

Minimal manifestation status and prednisone withdrawal in the MGTX trial

artículo científico publicado en 2020

Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis

artículo científico publicado en 2009

Myasthenia Gravis: Classification and Outcome Measurements

article

Myasthenia gravis

artículo científico publicado en 2012

North America and South America (NA-SA) neuropathy project

artículo científico publicado en 2013

Ocular myasthenia gravis - How effective is low dose prednisone long term?

artículo científico publicado en 2020

Painful Peripheral Neuropathy

artículo científico publicado en 2002

Painful peripheral neuropathy and its nonsurgical treatment

artículo científico publicado en 2004

Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension

scientific article published on 23 November 2020

Posterior reversible encephalopathy syndrome secondary to blood transfusion

artículo científico publicado en 2014

Primary lateral sclerosis

scientific article published on 01 March 2007

Primary lateral sclerosis: clinical and laboratory features in 25 patients

scientific article published on 01 September 2005

Randomized Trial of Thymectomy in Myasthenia Gravis

artículo científico publicado en 2016

Randomized Trial of Thymectomy in Myasthenia Gravis.

artículo científico publicado en 2016

Randomized trial of thymectomy in myasthenia gravis.

artículo científico publicado en 2016

Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis

artículo científico publicado en 2002

Recommendations for myasthenia gravis clinical trials

artículo científico publicado en 2012

Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis

artículo científico publicado en 2006

Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review

artículo científico publicado en 2008

Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study

scientific article published on 01 October 2018

Rituximab in Treatment-Refractory Myasthenia Gravis.

artículo científico publicado en 2017

Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials

artículo científico publicado en 2020

Start high, then go low: An effective strategy in the treatment of myasthenia gravis

artículo científico publicado en 2017

Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial ⬇️

artículo científico publicado el 1 de mayo de 2003

Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone

artículo científico publicado en 2008

The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis

artículo científico publicado en 2011

The MGTX experience: challenges in planning and executing an international, multicenter clinical trial

artículo científico publicado en 2008

Therapy update in nerve, neuromuscular junction and myopathic disorders ⬇️

artículo científico publicado el 1 de octubre de 2010

Transverse myelitis in systemic sclerosis

scientific article published on 01 January 2004

Treatment of painful peripheral neuropathy

artículo científico publicado en 2013

Treatment of painful peripheral neuropathy.

artículo científico publicado en 2002

Treatment review and update for myasthenia gravis

artículo científico publicado en 2004

Treatment-refractory myasthenia gravis

artículo científico

Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States

artículo científico publicado en 2015

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI

Von hippel-lindau disease associated with thymoma and myasthenia gravis

artículo científico publicado en 2005

What's in the Literature?

artículo científico publicado en 2016

What's in the Literature?

artículo científico publicado en 2016

What's in the Literature?

artículo científico publicado en 2017

What's in the Literature?

scientific article published on 01 December 2016

Lista de obras de

A Neurologist's Perspective on Thymectomy for Myasthenia Gravis: Current Perspective and Future Trials

A genome-wide association study of myasthenia gravis

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

Adult polyglucosan body disease associated with lewy bodies and tremor

Alfred Jaretzki III, MD.

Antibody testing in peripheral neuropathies

Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia).

Author response: International consensus guidance for management of myasthenia gravis: Executive summary

Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome

Biomarker development for myasthenia gravis

Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome

CMT with vocal cord paralysis, type 2C

Cerebral paragonimiasis: an unusual manifestation of a rare parasitic infection

Challenges in the identification of cobalamin-deficiency polyneuropathy

Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sample

Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience

Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis

Comment: Salbutamol--A means to an endplate

Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches

Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis

Consensus treatment recommendations for late-onset Pompe disease

Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study

Cytokines in Guillain-Barré Syndrome

Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial

Developing treatment guidelines for myasthenia gravis

Development of a Thymectomy Trial in Nonthymomatous Myasthenia Gravis Patients Receiving Immunosuppressive Therapy ⬇️

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria

Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy

Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.

Idiopathic neuropathy: new paradigms, new promise.

Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?

Implementing clinical trials on an international platform: challenges and perspectives

International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r

International consensus guidance for management of myasthenia gravis: 2020 update

International consensus guidance for management of myasthenia gravis: Executive summary

Introduction for Myasthenia Gravis and Related Disorders

Introduction for myasthenia gravis and related disorders

Is the treatment of myasthenia gravis improving? Why not ask our patients?

Isolated Neck Extensor Myopathy: Is it Responsive to Immunotherapy? ⬇️

Learning from the past: reflections on recently completed myasthenia gravis trials

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Low-Dose Medication and Long-Term Outcome in Myasthenia Gravis

MG‐ADL: Still a relevant outcome measure ⬇️

MRI vs EMG: which has the upper hand in carpal tunnel syndrome?

Minimal manifestation status and prednisone withdrawal in the MGTX trial

Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis

Myasthenia Gravis: Classification and Outcome Measurements

Myasthenia gravis

North America and South America (NA-SA) neuropathy project

Ocular myasthenia gravis - How effective is low dose prednisone long term?

Painful Peripheral Neuropathy

Painful peripheral neuropathy and its nonsurgical treatment

Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension

Posterior reversible encephalopathy syndrome secondary to blood transfusion

Primary lateral sclerosis

Primary lateral sclerosis: clinical and laboratory features in 25 patients

Randomized Trial of Thymectomy in Myasthenia Gravis

Randomized Trial of Thymectomy in Myasthenia Gravis.

Randomized trial of thymectomy in myasthenia gravis.

Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis

Recommendations for myasthenia gravis clinical trials

Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis

Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review

Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study

Rituximab in Treatment-Refractory Myasthenia Gravis.

Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials

Start high, then go low: An effective strategy in the treatment of myasthenia gravis

Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial ⬇️

Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone

The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis

The MGTX experience: challenges in planning and executing an international, multicenter clinical trial

Therapy update in nerve, neuromuscular junction and myopathic disorders ⬇️

Transverse myelitis in systemic sclerosis

Treatment of painful peripheral neuropathy